Harpoon Therapeutics (HARP)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	17.94 mm	17.94 mm	17.94 mm	17.94 mm	17.94 mm	17.94 mm
Cash burn (monthly)	5.18 mm	2.76 mm	4.05 mm	3.26 mm	5.51 mm	5.78 mm
Cash used (since last report)	91.12 mm	48.56 mm	71.24 mm	57.40 mm	97.00 mm	101.79 mm
Cash remaining	-73.17 mm	-30.62 mm	-53.30 mm	-39.46 mm	-79.06 mm	-83.85 mm
Runway (months of cash)	-14.1	-11.1	-13.2	-12.1	-14.3	-14.5

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2024

HARP institutional ownership history Ownership history

47.5% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	7	7	–
Opened positions	0	1	EXIT
Closed positions	0	5	EXIT
Increased positions	0	0
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	92.86 mm	92.86 mm	–
Total shares	17.87 mm	17.87 mm	–
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
New Leaf Ventures III	3.91 mm	$2.69 mm	0.0%
MPM BioVentures 2014	3.40 mm	$77.02 mm	0.0%
Arix Bioscience	3.24 mm	$2.23 mm	0.0%
Merck Sharp & Dohme	3.08 mm	$0.00	0.0%
Artal International S.C.A.	2.35 mm	$1.61 mm	0.0%
Soleus Private Equity Fund III	1.87 mm	$9.32 mm	0.0%
Integrated Core Strategies	25.47 k	$0.00	0.0%

Largest transactions	Shares	Change
Merck Sharp & Dohme	3.08 mm	0.0%
Artal International S.C.A.	2.35 mm	0.0%
Integrated Core Strategies	25.47 k	0.0%
MPM BioVentures 2014	3.40 mm	0.0%
New Leaf Ventures III	3.91 mm	0.0%
Arix Bioscience	3.24 mm	0.0%
Soleus Private Equity Fund III	1.87 mm	0.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

HARP insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
11 Mar 24	Merck & Co.	Common Stock, par value $0.0001	Buy	Acquire P	Yes	No	23	21,397,205	492.14 mm	1,000
11 Mar 24	Silvernail Lauren P	Common Stock	Sale back to company	Dispose D	No	No	0	5,000	0.00	0
11 Mar 24	Silvernail Lauren P	Director Stock Option Common Stock	Sale back to company	Dispose D	No	No	6.657	2,300	15.31 k	0
11 Mar 24	Silvernail Lauren P	Director Stock Option Common Stock	Sale back to company	Dispose D	No	No	16.2	2,033	32.93 k	0
11 Mar 24	Luke Nathaniel Walker	Common Stock	Sale back to company	Dispose D	No	No	0	135,000	0.00	0
11 Mar 24	Luke Nathaniel Walker	Employee Stock Option Common Stock	Sale back to company	Dispose D	No	No	8.9	10,000	89.00 k	0
11 Mar 24	Luke Nathaniel Walker	Employee Stock Option Common Stock	Sale back to company	Dispose D	No	No	10.8	30,500	329.40 k	0
11 Mar 24	Myers Scott Dunseth	Common Stock	Sale back to company	Dispose D	No	No	0	22,665	0.00	0
11 Mar 24	Myers Scott Dunseth	Director Stock Option Common Stock	Sale back to company	Dispose D	No	No	6.657	4,600	30.62 k	0
11 Mar 24	Myers Scott Dunseth	Director Stock Option Common Stock	Sale back to company	Dispose D	No	No	20.1	2,033	40.86 k	0

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.